Laurus Labs Limited — Sitagliptin Exporter Profile
Indian Pharmaceutical Exporter · #15 for Sitagliptin · $500.0K export value · DGFT Verified
Laurus Labs Limited is the #15 Indian exporter of Sitagliptin with $500.0K in export value and 10 verified shipments. Laurus Labs Limited holds a 0.7% market share in Sitagliptin exports across 2 countries. The company exports 4 pharmaceutical products worth $3.2M across 2 therapeutic categories.
Laurus Labs Limited — Sitagliptin Export Profile: Buyers & Destinations
Where Does Laurus Labs Limited Export Sitagliptin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SLOVENIA | $450.0K | 9 | 53.5% |
| CANADA | $391.7K | 12 | 46.5% |
Laurus Labs Limited exports Sitagliptin to 2 countries. The largest destination is SLOVENIA accounting for 53.5% of Laurus Labs Limited's Sitagliptin shipments. These destinations reflect Laurus Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sitagliptin from Laurus Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| KRKA D D NOVO MESTO | SLOVENIA | $350.0K | 7 |
| XXMP XXARMXXCORXXRATXXN | CANADA | $195.9K | 6 |
| JAMP PHARMA CORPORATION | CANADA | $195.8K | 6 |
| XXKA XX DXX NOXX MEXXO | SLOVENIA | $100.0K | 2 |
Laurus Labs Limited supplies Sitagliptin to 4 buyers globally. The largest buyer is KRKA D D NOVO MESTO (SLOVENIA), followed by XXMP XXARMXXCORXXRATXXN (CANADA) and JAMP PHARMA CORPORATION (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sitagliptin Export Value and How Much Does Laurus Labs Limited Contribute?
India exported $46.1M worth of Sitagliptin through 5,364 shipments from 309 suppliers to 121 countries, serving 575 buyers globally. Laurus Labs Limited contributes $500.0K to this total, accounting for 0.7% of India's Sitagliptin exports. Laurus Labs Limited ships Sitagliptin to 2 countries through 4 buyers.
What Is the Average Shipment Value for Laurus Labs Limited's Sitagliptin Exports?
Laurus Labs Limited's average Sitagliptin shipment value is $50.0K per consignment, based on 10 shipments totaling $500.0K. The largest destination is SLOVENIA (53.5% of Laurus Labs Limited's Sitagliptin exports).
How Does Laurus Labs Limited Compare to Other Indian Sitagliptin Exporters?
Laurus Labs Limited ranks #15 among 309 Indian Sitagliptin exporters with a 0.7% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($7.7M), MYLAN LABORATORIES LIMITED ($7.0M), SANDOZ PRIVATE LIMITED ($6.5M). Laurus Labs Limited processed 10 shipments to 2 destination countries.
What Sitagliptin Formulations Does Laurus Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SITAGLIPTIN AND METFORMIN FILM COATED | $200.0K | 4 |
| SITAGLIPTIN TABLETS 100MG 500'S | $200.0K | 4 |
| SITAGLIPTIN TABLETS 100MG 100'S | $147.1K | 4 |
| SITAGLIPTIN AND METFORMN FILM COATED | $100.0K | 2 |
| SITAGLIPTIN AND METFORMIN FILM-COATED | $100.0K | 2 |
| SITAGLIPTIN AND -METFORMIN FILM COATED | $50.0K | 1 |
| SITAGLIPTIN TABLETS 50MG 1000'S | $17.9K | 1 |
| SITAGLIPTIN TABLETS 50MG1000'S | $17.9K | 1 |
| SITAGLIPTIN TABLETS 25MG 1000'S | $8.9K | 2 |
Laurus Labs Limited exports 9 distinct Sitagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SITAGLIPTIN AND METFORMIN FILM COATED with 4 shipments worth $200.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Sitagliptin to Key Markets
What Laurus Labs Limited must comply with to export Sitagliptin to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Laurus Labs Limited Compare to Nearest Sitagliptin Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | DR REDDY S LABORATORIES LTD | $1.3M | 26 | 4 | $50.0K |
| 14 | ZENTIVA PRIVATE LIMITED | $1.1M | 23 | 4 | $50.0K |
| 15 | LAURUS LABS LIMITED ★ | $500.0K | 10 | 2 | $50.0K |
| 6 | ZYPHER LIFESCIENCES PRIVATE LIMITED | $150.0K | 3 | 1 | $50.0K |
Laurus Labs Limited ranks #15 among 309 Indian Sitagliptin exporters. Average shipment value of $50.0K compared to the market average of $149.3K. The closest competitors by value are DR REDDY S LABORATORIES LTD and ZENTIVA PRIVATE LIMITED.
Which Indian Ports Ship Sitagliptin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 772 | 14.4% |
| DELHI AIR CARGO ACC (INDEL4) | 739 | 13.8% |
| SAHAR AIR | 735 | 13.7% |
| DELHI AIR | 513 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 217 | 4.0% |
| HYDERABAD AIR | 213 | 4.0% |
| Bombay Air | 196 | 3.7% |
| HYDERABAD ACC (INHYD4) | 191 | 3.6% |
About Laurus Labs Limited
Laurus Labs Limited exports 4 products worth $3.2M. Beyond Sitagliptin, top products include Dolutegravir, Emtricitabine, Tenofovir. View the complete Laurus Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sitagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Laurus Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 21 individual customs records matching Laurus Labs Limited exporting Sitagliptin, covering 9 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 575+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sitagliptin Export Data from Laurus Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Laurus Labs Limited's Sitagliptin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Laurus Labs Limited
Full Company Profile →
4 products · $3.2M total trade · 2 categories
Sitagliptin Stats
Company Overview
Top Products by Laurus Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Laurus Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sitagliptin. For current shipment-level data, contact TransData Nexus.